Trupanion Stock Forecast, Price & News

Trupanion (NASDAQ:TRUP) Frequently Asked Questions

Is Trupanion a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Trupanion in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Trupanion stock.
View analyst ratings for Trupanion or view top-rated stocks.

How has Trupanion's stock price been impacted by COVID-19 (Coronavirus)?

Trupanion's stock was trading at $26.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TRUP shares have increased by 330.7% and is now trading at $112.15.
View which stocks have been most impacted by COVID-19.

When is Trupanion's next earnings date?

Trupanion is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022.
View our earnings forecast for Trupanion.

How were Trupanion's earnings last quarter?

Trupanion, Inc. (NASDAQ:TRUP) announced its earnings results on Wednesday, November, 3rd. The financial services provider reported ($0.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.18) by $0.01. Trupanion had a negative net margin of 4.94% and a negative trailing twelve-month return on equity of 8.69%. During the same period last year, the firm earned ($0.07) EPS.
View Trupanion's earnings history.

What price target have analysts set for TRUP?

5 analysts have issued twelve-month price objectives for Trupanion's stock. Their forecasts range from $100.00 to $150.00. On average, they expect Trupanion's stock price to reach $127.80 in the next year. This suggests a possible upside of 14.0% from the stock's current price.
View analysts' price targets for Trupanion or view top-rated stocks among Wall Street analysts.

Who are Trupanion's key executives?

Trupanion's management team includes the following people:

• Darryl Rawlings, Chief Executive Officer & Director
• Tricia Plouf, Co-President (LinkedIn Profile)
• Margaret Tooth, Co-President & Chief Revenue Officer (LinkedIn Profile)
• Andrew Wolff, Chief Financial Officer
• Chris Cappelletti, Chief Technology Officer

What is Darryl Rawlings' approval rating as Trupanion's CEO?

139 employees have rated Trupanion CEO Darryl Rawlings on Glassdoor.com. Darryl Rawlings has an approval rating of 76% among Trupanion's employees.

Who are some of Trupanion's key competitors?

Some companies that are related to Trupanion include Molina Healthcare (MOH), Alignment Healthcare (ALHC), Bright Health Group (BHG), Clover Health Investments (CLOV) and Oscar Health (OSCR).
View all of TRUP's competitors.

What other stocks do shareholders of Trupanion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trupanion investors own include CA (CA), Micron Technology (MU), Chipotle Mexican Grill (CMG), McEwen Mining (MUX), Pfizer (PFE), Splunk (SPLK), AbbVie (ABBV), Abbott Laboratories (ABT), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).

What is Trupanion's stock symbol?

Trupanion trades on the NASDAQ under the ticker symbol "TRUP."

Who are Trupanion's major shareholders?

Trupanion's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (14.24%), Wellington Management Group LLP (5.67%), Baillie Gifford & Co. (3.53%), Alliancebernstein L.P. (3.26%), Geode Capital Management LLC (1.81%) and Morgan Stanley (1.30%). Company insiders that own Trupanion stock include Asher Bearman, Dan Levitan, Darryl Rawlings, Gavin Friedman, H Hays Lindsley, Howard E Rubin, Margaret Tooth, Michael Doak, Murray B Low, Robin A Ferracone and Tricia Plouf.
View institutional ownership trends for Trupanion.

Which institutional investors are selling Trupanion stock?

TRUP stock was sold by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, BlackRock Inc., Avenir Corp, Karani Asset Management LLC, Wellington Management Group LLP, Allianz Asset Management GmbH, Capital Research Global Investors, and Two Sigma Advisers LP. Company insiders that have sold Trupanion company stock in the last year include Asher Bearman, Darryl Rawlings, Gavin Friedman, H Hays Lindsley, Howard E Rubin, Margaret Tooth, Michael Doak, Murray B Low, and Tricia Plouf.
View insider buying and selling activity for Trupanion or view top insider-selling stocks.

Which institutional investors are buying Trupanion stock?

TRUP stock was bought by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., Pura Vida Investments LLC, Tsai Capital Corp, Millennium Management LLC, Cinctive Capital Management LP, Dimensional Fund Advisors LP, Voloridge Investment Management LLC, and Twinbeech Capital LP.
View insider buying and selling activity for Trupanion or or view top insider-buying stocks.

How do I buy shares of Trupanion?

Shares of TRUP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Trupanion's stock price today?

One share of TRUP stock can currently be purchased for approximately $112.15.

How much money does Trupanion make?

Trupanion has a market capitalization of $4.53 billion and generates $502.03 million in revenue each year. The financial services provider earns $-5.84 million in net income (profit) each year or ($0.80) on an earnings per share basis.

How many employees does Trupanion have?

Trupanion employs 911 workers across the globe.

What is Trupanion's official website?

The official website for Trupanion is www.trupanion.com.

Where are Trupanion's headquarters?

Trupanion is headquartered at 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108.

How can I contact Trupanion?

Trupanion's mailing address is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. The financial services provider can be reached via phone at (888) 733-2685, via email at [email protected], or via fax at 866-405-4536.